Transcription factor hTFinC was purified from cytoplasmic extracts of HeLa cells using four different chromatographic steps. This procedure yields a protein fraction which actively supports transcription in reconstitution assays and contains five major polypeptide chains with a molecular mass ranging from 25 to 250 kDa as estimated by SDS-PAGE and silver staining. In this fraction a polypeptide with a molecular mass of approximately 110 kDa could be identified as a specific DNA-binding component of hThlllC. By electrophoretic mobility shift and footprinting analyses it could be demonstrated that purified h'l'hlllC binds specifically to the 5S gene. The protected region encompasses the A-Box promoter element and flanking sequences extending toward the 5'-proximal end of the gene. By addition of hTFlIIC to preformed TFUIA/5S DNA complexes, we observe an additive effect of both factors on the footprint boundaries.
INTRODUCTION
Genes transcribed by RNA-polymerase HI (class HI genes) encode several small RNAs including tRNA, 5S rRNA and the adenovirus associated VA-RNAs (reviewed in 1). Specific initiation of transcription of these genes requires that accessory transcription factors (TF) interact with the class m internal control regions to effect promoter recognition by RNA polymerase III (Pol 111). By studying Pol HI transcription in vitro, at least two general protein factors called ThlilB and TFIIIC were identified by chromatographic separation of crude cellular extracts. In the case of 5S-RNA genes an additional and gene specific transcription factor, TFTHA, is required (2, 3) , which has been purified and extensively characterized as a zinc-finger protein from Xenopus oocytes (1, 4) . The corresponding proteins from human and yeast-cells have been purified only very recently (5, 6) . Likewise, transcription factor ThlliB which is not a primary DNA-binding protein has only recently been isolated from yeast- (7) and human cells (8) .
In contrast to these fairly well characterized polypeptides, little is known about the molecular structure of transcription factor IEC (TFIIIC) from mammalian cells. By functional analyses of crude fractions it has been shown that '1'FiilC is the primary DNAbinding protein required for the transcription of tRNA and VA-RNA genes (9) (10) (11) (12) (13) , whereas its function during 5S-RNA transcription still remains unclear. Attempts to directly analyze TFIIIC interactions with the 5S-gene by DNase I protection assays were hitherto unsuccessful] (14, 15) . However, it was concluded indirectly, on the basis of transcriptional analyses of a series of point mutations created within the 5S-gene, that besides the two functional promoter domains, Box A and Box C (16, 17) , sequences located near the 5'-boundary of the internal promoter (18) may be additionally involved in the binding of TFH3C to the 5S gene either by protein:DNA or protein:protein interactions (15, 17) . Unfortunately the purification of TFTJJC from human cells has up to now proven to be extremely difficult, and only its functional equivalent from yeast-cells, the so called 7-factor, has been extensively purified. Its functional activity could be correlated with a protein fraction containing several polypeptides ranging from 50 to 170 kDa (19) . The chromatographic purification of human TFIIIC (hTFTJIC) on FPLC-Mono Q or DNA affinity columns led to a separation into two functionally distinguishable protein fractions, called TFIIIC 1 and TFTIIC2 (20, 21) . While TFTUC2 shows promoter specific DNA-binding to tRNA and adenovirus associated VA-RNA genes, both TFIIIC 1 and TFTDC2 are required for efficient transcription of these genes (20) (21) (22) . Despite these functional data, only little is known about the polypeptide composition of these protein fractions and their molecular dimensions, which reportedly range over a relative molecular mass from about 45 to 500 kDa (20, 21) . In the present study we report a method for the extensive purification of human transcription factor mC, the identification of a specific DNA-binding component and the direct interaction of hTFTJIC with the gene for ribosomal 5S RNA. 
MATERIALS AND METHODS

Plasmids
The plasmid pUXls (16) contains a single copy of the gene for somatic 5S-rRNA from Xenopus laevis. The plasmid pUVAl was constructed by excising the 231 bp Sail/AM VA1-fragment from the plasmid pVA (23) and subcloning it into pUC 18 using the Hinc II site. The plasmid pUht Met i was subcloned by excising the AluI/Hpall-fragment from phH 2 D containing the human gene for tRNA Ma i (24) and inserting it into the Hinc II site of pUC18. All plasmids were isolated in their superhelical form as described previously (25) .
In vitro transcription
The in vitro transcription reactions were performed as described (26). Modifications are specified in the legends to the individual figures. Cells and extract fractionation All operations were performed at 0-4°C unless stated otherwise. Cytoplasmic extracts (SI00) from HeLa suspension cultures were prepared as described (5) . The following buffers were employed for the fractionation procedure. Buffer A was 20 mM Hepes, pH 7.9, 20 % (v/v) glycerol, 3 mM DTT, 0.2 mM PMSF, Buffer B was 20 mM Hepes, pH 7.9, 20 % (v/v) glycerol, 5 mM MgCI 2 , 3 mM DTT, 0.2 mM PMSF; Buffer C was 20 mM Tris-HCl, pH 7.9; 20 % (v/v) glycerol 5 mM MgCl 2 , 3 mM DTT, 0.2 mM PMSF and Buffer D was 20 mM Tris-HCl, pH 7.9; 60 mM KC1, 10 % (v/v) glycerol, 5 mM MgCl 2 , 3 mM DTT, 0.2 mM PMSF. Phosphocellulose (Whatman PI 1) was prepared in its sodium form (27) and equilibrated with buffer A plus 0.1 M KC1. Cytoplasmic HeLa cell extract (S100; 15 mg of protein/ml) was loaded onto the column at 10 mg of protein per ml of bed volume, followed by washing the column with several volumes of the same buffer. Bound proteins were then eluted with two consecutive steps of buffer A containing 0.35 M KC1 (fraction B, 3,1 mg of protein/ml) and 0.6 M KC1 (fraction C, 1,2 mg of protein/ml). Following dialysis, fraction C was loaded onto CM-Sepharose 6B (Pharmacia/LKB Inc., equilibrated with buffer B plus 35 mM ammonium sulfate) at 1 mg protein per ml of bed volume. After washing the column, bound proteins were eluted with 0.3 M ammonium sulfate in buffer B. This fraction, containing TFIIIC activity, was pooled (0.83 mg of protein/ml), dialyzed against buffer C plus 50 mM ammonium sulfate and subsequently applied to a DEAE-Sephadex column (A-25, Pharmacia/LKB Inc., equilibrated with buffer C containing 50 mM ammonium sulfate) at a capacity of 1 mg per ml bed volume. The column was washed with two volumes of the loading buffer and bound proteins were consecutively eluted with buffer C plus 0.15 M and 1.0 M ammonium sulfate respectively. The 0.15 M fraction, which contained 0.052 mg of protein/ml was then directly loaded onto a Heparin-Agarose column (Sigma) using 1 mg protein per ml bed volume. This matrix was equilibrated with the same buffer as the DEAE-Sephadex column. After washing the column, bound proteins were eluted with two consecutive steps of buffer C containing 0.4 M and 1 M ammonium sulfate respectively. The latter fraction contained about 0.022 mg of protein/ml. After dialysis against transcription buffer D, the fractions were analyzed for TFlilC activity in the in vitro transcription assay. Protein concentrations in the various column fractions were determined by the method of Bradford (28) .
SDS-Polyacrylamide Gradient Gel Electrophoresis
Proteins present in the individual column fractions obtained in the course of purification described above, were separated on SDS containing 5 -20 % gradient polyacrylamide gels as described previously (5) and the protein bands were visualized by staining the gel with the 'Bio Rad Silver Stain Kit'.
Protein-DNA-Blot ('South-Western')
After electrophoresis on 5-20 % SDS polyacrylamide gradient gels, hTFIIIC fractions purified by Heparin-Agarose were electrophoretically transferred to a nitrocellulose filter membrane using the 'semi dry blot technique' of Kyhse-Andersen (29) . Nitrocellulose filters with blotted proteins were washed for 1 h in SW buffer (10 mM Tris-HCl; pH 7.5; 50 mM NaCl, 0.5 % BSA, 0.05 % Ficoll, 0.05 % Polyvinylpyrrolidone) and then preincubated with SW buffer containing 0.2 mg/ml sonicated calf thymus (ct) DNA. The binding reactions with either 1 X10 7 cpm/ml multiprime labelled (Amersham Multiprime labelling Kit) EcoRI/HindM fragments of pUVAl and pUhf^i or bacteriophage lambda DNA as control were performed for 12 h in SW buffer in the presence of 0.2 mg/ml sonicated ct DNA. After incubation, the filters were washed twice with SW buffer and twice with 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, and subsequently autoradiographed for 48 h. Binding of hTFIIIC to a 249 bp fragment containing the Xenopus laevis somatic 5S gene and prepared as described in Materials and Methods. Lane I: without protein, samples in lanes 2-11 contained 25 /il of hTFIIIC and were handled as described in Materials and Methods. Lanes 3 to 5 were preincubated with a lOfold, 40fold, and I60fold molar excess of unlabelled VAl-fragment before addition of the labelled fragment. Lanes 6 to 8 were preincubated with a 20fold, lOOfold, and SOOfold molar excess of unlabelled 5S-DNA fragment. Lanes 9 to 12 contained a 150fold, 300fold, 600fold and 1200fold molar excess of poly dldC. Pan B: Binding of hTFIIIC to a 281 bp fragment containing the VAl-gene. Otherwise, lanes I to 12 were identical in composition and handling to partA.
Electrophoretic Mobility Shift Analysis of DNA-Protein Complexes
EcoRI-Hindm fragments of pUVAl and pUXls (3 f mol), labelled with [cr^PJdATP by the KJenow fragment of DNA polymerase I, was conducted for 30 min at 30°C in 25 n\ of 20 mM Tris-HCl (pH 7.9), 5 mM MgCl 2 , 60 mM KC1, 3 mM DTT, 10 % glycerol, 0.2 mM PMSF, bovine serum albumin (300 /ig/ml) and poly-dldC (24 /tg/ml). Where appropriate, samples were preincubated with competitor DNA for 20 min as indicated in the legend of Figure 5 . Protein-DNA complexes were resolved on 4 % polyacrylamide gels (acrylamide/N,N-methylene bisacrylamide, 80:1 (wt/wt)) in 6.7 mM Tris-HCl (pH 7.5), 1 mM EDTA, 3.3 mM sodium acetate, 2.5 % glycerol and omitting glycerol from the electrode buffer. The gels were prepared at least 2 hours before use, prerun for 90 min at 100 V, and run at 150 V at 4°C with recirculation of electrode buffer and change of buffer every 30 min.
DNasel Footprinting Experiments
Labelling of the DNA-Fragments: A 214 bp fragment containing the Xenopus laevis somatic 5S gene was 3'-labelled as described (5) . A 273 bp fragment containing the VA1 gene was prepared by cleaving pUVAl with EcoRI/HindED, followed by 3'-labelling with the Klenow fragment of DNA polymerase I and (a-32 P) dATP, and a second restriction digest of the DNA fragment with Pstl.
Protein fractions: TFHLA was purified from 7S-particles of Xenopus laevis ovaries as described (30) . Footprint analyses of hTFIIIC were conducted with the DEAE-Sephadex fraction (0.4 mg of protein/ml) eluted with 0.15 M and subsequently concentrated by precipitation with ammonium sulfate as described above. DNase I footprinting reactions were performed as described previously (5) .
RESULTS
Partial purification of human TFWC from HeLa cells
We describe here a procedure to extensively purify hTFIIIC from cytoplasmic HeLa cell extracts (S100). As outlined in Fig. 1 , the purification protocol involves four consecutive steps of column chromatography on Phosphocellulose. CM-Sepharose, DEAE-Sephadex and finally on Heparin-Agarose. It should be pointed out that all columns were step-eluted with the indicated salt concentrations. The individual elution points were arrived at in pilot experiments employing gradient elution techniques.
Step elution leads to more concentrated protein fractions, which do not require stabilization by BSA supplementation. Fractionation of the cellular extract on phosphocellulose results in the classical separation of Pol ru transcription factors (2) . The fraction obtained after elution with 0.35 M KCl, containing TFEQB and Pol in but no detectable TFmC activity (Fig. 2, lane 3) , was used in combination with fractions from the various stages of purification to reconstitute specific transcription from a cloned VA1-RNA gene. As shown in Fig. 2 The results from this purification scheme reveal that chromatography on CMSepharose gave excellent yields of activity (Fig. 2, lane 6 ) and resulted in sufficient purification to successfully conduct the subsequent DEAE-Sephadex chromatography. Chromatography on DEAE-Sephadex yielded the most powerful purification of TFIIIC activity and simultaneously separated the bulk of RNA-polymerase m into the 1 M ammonium sulfate fraction. It should be pointed out that the high resolution of this anion exchanger varies between batches and strictly depends on the loading capacity. When 1 mg protein per ml DEAE-Sephadex bed volume was exceeded, TFIHC activity was splitted into various column fractions. However, by reconstituting these and other column fractions in a transcription assay with TFTUB and Pol IE (data not shown), we could not detect any resolution of hTFIIIC into two functionally distinct components as described previously by Berk and coworkers (20, 21) . Affinity chromatography on Heparin-Agarose, the final step in our purification procedure, results in a partial loss of activity into the fractions eluted with 0.4 M (Fig. 2, lane 10 ), but provides a significant purification of the activity eluted with 1.0 M ammonium sulfate (Fig. 3, compare lane 7 and 8) . In our procedure, the steps providing the most efficient purification (on the basis of protein content and hTFIIIC activity) are phosphocellulose, DEAE-Sephadex and the Heparin-Agarose columns (Fig. 3, compare lanes 1, 2, 5 and 8) .
Analysis of purified fractions on 5-20 % SDS-PAGE
Individual fractions, obtained from the various purification steps, were analyzed by 5-20 % SDS-polyacrylamide gradient gel electrophoresis as shown in Fig. 3 . We find that human transcription factor IDC could be purified by the outlined procedure (Fig. 1) to a fraction which is transcriptionally active and contains five predominant polypeptides (Fig. 3, lane  8) . These polypeptides were minimally contained in the final purification step of several different preparations showing hTFIIIC activity in reconstitution assays. Two of these demonstrate a molecular mass of about 220 and 250 kDa, two have about 110 and 120 kDa and one approximately 25 kDa. Additional results from preliminary gel filtration and glycerol gradient centrifugation analyses with purified fractions containing TFIIIC activity, also demonstrate that the molecular dimensions of the native transcription factor are larger than 100 kDa (data not shown), indicating that hTFIIIC might possibly exert its function as a multi subunit complex.
Identification of a specific DNA binding component of hTFIIIC
Additional studies, concerning the molecular properties of hTFIIIC were conducted by analyzing the interactions of components, present in the transcriptionally active fraction, with Pol HI gene sequences in 'South-Western' blotting experiments. As shown in Fig.  4 , a polypeptide of about 110-120 kDa binds to tRNA-and VA1 RNA genes but not to irrelevant X-DNA (Fig. 4 ; compare lane 1 with 2 and 3). At this stage of investigation it should be noted that (i) the identified protein might be larger in its native state and that (ii) there could be additional polypeptides responsible for the specific DNA binding of hTFIIIC. Attempts to show binding of hTFIIIC to the 5S promoter by the 'South-Western' technique were unsuccessful, presumably because the lower affinity of binding to the 5S gene (see discussion below) precludes its detection by this rather insensitive method. Binding of purified hTFIIIC to 5S DNA Despite numerous attempts (14, 15) , primary binding of human TFmC to 5S-RNA genes by DNasel footprinting analyses has hitherto not been demonstrated, although it has been reported that TFIEC functionally interacts with the 5S gene promoter (16, 17, 18) . To test whether partially purified fractions of hTFIIIC would bind to the 5S gene, we employed electrophoretic mobility shift analyses of DNA-protein complexes described by Fried and Crothers (31) . Since binding reactions require higher protein concentrations than transcription assays, the most highly purified Heparin-Agarose hTFIIIC fractions (Fig.  1) could not be employed for these experiments. Therefore the DEAE-Sephadex fraction which was transcriptionally highly active was used for the binding studies described. The results in Fig. 5A show that incubation of hTFIIIC with a fragment containing the 5S gene leads to a clear reduction in the mobility of this fragment (compare lanes 1 and 2). Addition of a 10-fold and greater excess of VAl competitor DNA, known to bind TFITJC with high affinity (lanes 3 to 5) abolishes binding of hTFIHC to the 5S gene. In contrast, a 20-fold molar excess of cold 5S DNA partially retains binding (lane 6) and a 100-fold or greater excess of this competitor is required to prevent complex formation (lanes 7 and 8). By comparison, binding is not inhibited by a 150-or 300-fold (lanes 9 and 10) and only partially reduced by a 600-fold and greater excess of irrelevant poly dldC Qanes 11 and 12).
An analogous experiment, analyzing the binding of hTFIIIC to the VAl-gene, is depicted in Fig. 5B . It shows that a 40-fold and greater excess of cold VAl-fragment is required to prevent binding (compare lanes 2 and 3 with lanes 4 and 5). In contrast, a 500-fold excess of cold 5S competitor is necessary to reduce complex formation on the VAl gene (compare lanes 6 to 8). The nonspecific competitor poly dldC has no effect on binding to the VAl-gene even at a 1200-fold molar excess (lanes 9 to 12). These results demonstrate that hTFIIIC specifically interacts not only with the VAl but also with the 5S gene in a primary fashion. From the competition experiments it can be deduced that the latter interaction occurs with an approximately 10-fold lower affinity than is observed for the VAl gene.
In extension of the gel retardation assays, we analyzed the interaction of hTFIIIC with the promoter of the 5S gene in more detail, employing the DNasel protection assay described by Galas and Schmitz (32) . The binding reactions of proteins to the different DNA-fragments were performed as described previously (5) . For control purposes, the DNA-binding activity of the h'l'hlllC fraction employed was analyzed for its well characterized promoter binding to the coding strand of the adenovirus VAl gene. As outlined in excellent agreement with described data (10, 20) , the results show that the fraction containing hTFIIIC activity specifically protects a region encompassing the B-Box promoter element (+40 to +80; solid bar). In addition we observed an additional region of protection preceding and extending into the transcription initiation site of the VA1 gene ( Fig. 6 ; open bar), the significance of which is presently unclear. Apart from the basic protection over the B-Box, other investigators have observed additional effects in the 3'flanking region (10) as well as in the 5'flanking region of the VA1 gene (20) by using different transcriptionally active TF11IC preparations. Fig. 7 shows the footprint of hTFIIIC conducted with increasing amounts of protein (lane 2-4) on the somatic Xenopus 5S gene. Lane 1 represents the control without protein.
In this experiment we demonstrate that partially purified hTFIIIC specifically binds to 5S DNA. In agreement with the conclusions drawn from the mobility shift experiments (Fig.  5) it was found that the quantity of hTFUIC required to yield a clear protection on the 5S gene was at least 5-to 10-fold higher than that needed for the protection of the VA1 gene indicating a specific, albeit much weaker interaction of this factor with 5S rRNA gene. Due to these high protein concentrations, digestion by DNasel is frequently less complete in these experiments, technically leading to a reduced resolution of the footprint pattern. While TFIIIA protects a region from position +45 to +96, covering the complete internal control region (1, 5) , hTFUIC interacts with a region encompassing the A-Box promoter element and extending toward the 5'-proximal part of the 5S gene flanking the internal control region (approximately nucleotides +25 to +65). In addition, a region situated over the initiation site of transcription of the 5S gene is protected as indicated by the open bars in Fig. 7 . Similar experiments were conducted with the synthetic human 5S gene (33) . The results demonstrate analogous boundaries of protection for the internal hThlilC footprint on the human 5S DNA (data not shown). Surprisingly, however, no protection was detected around the initiation site of the human gene, which could be due to missing authentic 5'-flanking sequences which are obviously absent from the synthetic human 5S gene.
Based on previously described data (9, 15) , we attempted to analyze the interaction of hTFIIIC with the 5S gene during the sequential assembly of RNA polymerase III transcription factors. In particular, possible cooperative effects with TFITJA were investigated. In the experiment shown in Fig. 8 , the somatic Xenopus 5S gene was preincubated with TH11A, the prior binding of which has previously been shown to be a prerequisite for stable binding of hTFIIIC to 5S DNA (9) . After addition of TFIIIC and prolongation of the incubation, the DNasel digestion reaction was performed. As shown in Fig. 8 the addition of TFmC to a preformed TFTHA-5S-DNA complex (lane 2) extends the boundaries of the 1' hlLLA footprint in an additive manner toward the 5'-end of the 5S gene (Fig. 8, compare lane 2 and 3 with lane 6) . Surprisingly, the joint interaction of ThlllA and TFIIIC with the 5S gene did not render the complex more stable in comparison to what is found for the individual factors. This was concluded from the fact that similar amounts of the hl'blllC fraction were required for 5S DNA protection in either case (Fig. 8 , compare lanes 2 and 3 with lanes 4-6).
DISCUSSION
The molecular architecture of transcription factor nJC has thusfar been characterized most extensively for the protein from yeast cells (19) . In mammalian cells, TFIIIC was functionally identified in rather crude protein fractions as a general transcription factor required for the expression of all Pol Ill-genes thusfar studied (1) . In the case of tRNA and VA RNA genes, these crude fractions provided a remarkable amount of information and delineated TFIIIC as the primary DNA-binding protein (9-13) required for the initiation of transcription of these genes. In contrast, little is known about the molecular interactions of hTMllC with target sequences of the 5S gene, presumably required for complex formation and transcription (9) . The lack of information regarding the primary interaction of TFIIIC with the 5S gene could obviously be due to the crude nature of the protein fractions analyzed.
We hence developed a protocol for the purification of hTFIIIC in which the activity of the protein was assayed by the reconstitution of transcription. In the course of several preparations, which involved chromatography on Phosphocellulose, CM-Sepharose, DEAESephadex, and Heparin-Agarose, the activity of hTFIQC in the final protein fractions could be correlated with at least five common major polypeptide chains. As analyzed by SDS-PAGE and silver staining, these polypeptides exhibit a molecular mass of approximately 25, 110, 120, 220, and 250 kDa respectively (Fig. 3) . In contrast to the results presented by Berk and coworkers, who could separate human TFHJC into two functionally distinct components (TFIIIC 1 and TFHIC2) either by B-block affinity (21) or FPLC-Mono Q chromatography (20), we did not observe this splitting of hTFIIIC activity during our purification procedure. This leads us to the assumption that our final protein fraction should contain both TFmCl and TFIIIC2 activities. It is conceivable that TFmCl and TFIIIC2, which were previously reported to have molecular weights of approximately 200 (20) and 250 (34) kDa respectively, could be contained in the final fraction obtained by our hTMllC purification procedure.
Analyses by the 'South-Western' blotting technique of purified hTFIIIC fractions with specific target sequences or nonspecific DNA demonstrated that a polypeptide of approximately 110 kDa is a component of the DNA binding activity of hTFIIIC. At this stage of the investigation we cannot exclude, however, that this polypeptide might represent a proteolytic fragment or that additional DNA-binding polypeptides could be contained in this fraction, undetectable by this rather insensitive method.Similar molecular dimensions of the DNA-binding components of T-factor from yeast were observed by Sentenac and coworkers who found by UV cross-linking and immunological studies that the yeast factor consists of at least two polypeptides with molecular weights of 145 and 100 kDa (19) . These conclusions have recently been confirmed by DNA-binding studies conducted with TFIIIC from yeast (35) . From data obtained with purified hTFIIIC fractions, as well as from glycerol gradient centrifugation and gel filtration studies (manuscript in preparation) which indicate a native molecular weight of hTFTIIC clearly larger than 100 kDa, we conclude that human TFIIIC could act as a multisubunit or multimeric protein as was also suggested for the yeast factor (19) . Further elucidation of the molecular structure of hThlilC has been impeded by the small amount of protein available. With the described purification procedure, however, we hope to obtain sufficient quantities of purified hTFIIIC for future studies.
As mentioned before, primary interactions of TFIIIC with the 5S gene have hitherto not been published, possibly because the protein was not sufficiently purified. We report results here from electrophoretic mobility shift analyses which show that hThlilC purified from Hela cells specifically interacts in a primary fashion with the 5S gene as well as the VA1-promoter (Fig. 5) . From competition experiments with unlabelled 5S and VAl-gene sequences it could be concluded that the interaction of hTFIIIC with the 5S gene is much weaker than the binding to the VA1 gene.
In extension of the mobility shift analyses, we conducted footprint experiments which conclusively show that apart from its interaction with the B-block element of the VAl-promoter (Fig. 6) , hTFIIIC specifically binds to the 5S gene promoter (Fig. 7) . The interaction with the 5S gene is much weaker than that observed for the VA1 promoter, since about ten-fold higher protein concentrations are required to observe the footprint on the 5S gene (Fig. 7) . This is probably another explanation, why the interactions have thusfar passed undetected. The hTFIIIC footprint detected, protects a region approximately from nucleotides +25 to +65 encompassing the A-block element of the 5S promoter and extending toward the 5'proximal end of the gene. It is striking that although the VA1 promoter also contains a conserved A-box, no binding to this element of the VA1 promoter is observed (Fig. 6) . This is probably due to the much higher affinity of TFIIIC to the B-block, and its presence in the VA1 promoter possibly precludes binding to the A-block of that gene. In agreement with results from the mobility shift experiments (Fig. 5) , competition experiments of the TFIIIC footprint on the 5S gene with cold B-block sequences completely abolished binding to the 5S gene (data not shown).
The footprint of hTFIIIC on the 5S gene, although encompassing a part of the internal control region, is clearly discernable from the TFIHA-footprint (Fig. 8) . The region identified by footprint analyses for the interaction of hTFIIIC with the 5S gene is in good agreement with functional data reported by other investigators. It has been shown by McConkey and Bogenhagen (18) that mutations in 5'-proximal sequences, flanking the A-box promoter element inhibit transcription but have no detectable effect on TFIIIA binding. This indicates that sequences within the gene, but proximal to the internal control region (ICR) of the 5S gene, are directly involved in formation of functional transcription complexes, perhaps by providing a binding site for a second DNA-binding transcription factor, conceivably TFIIIC. By measuring THilC binding to preformed complexes formed between 1H111A and several 5S DNA-mutants, Pieler and coworkers concluded that nucleotides in the A-box element participate in TFIIIC binding (17) . Recent results from yeast also demonstrate that protection mediated by the binding of yeast TFHLA to the 5S gene was extended both distally and proximally of the ICR in the presence of yeast transcription factor HIC (36) .
We observed a second region of protection against DNase I which was localized around the transcription initiation site of the 5S gene (Fig. 7) . This binding is, however, not specific for the 5S gene, since we observe a similar protection in footprint reactions on the VA1 gene (Fig. 6) . The functional significance of this binding, which has also been observed by other investigators (10, 20) , is presently unclear. Analogous experiments with the transcriptionally active synthetic human 5S gene, missing 5'-flanking sequences preceeding the initiation site, do not reveal this area of protection. On this gene the hTFlilC fraction exclusively contacts the region surrounding the A-box promoter element (data not shown) with the identical boundaries found for the Xenopus 5S-gene (Fig. 6) . From the recollection that the transcription activity of the synthetic gene is reduced in comparison to the Xenopus 5S-gene (33), we conclude that protein binding at the initiation site might be involved in modulating the efficiency of transcription. It was described in the Xenopus system by Reynolds and Azer (37) that sequences in this region supposedly participate in the oocyte to somatic switch and could be involved in the differential modulation of 5S gene expression.
Future studies, involving further purification and characterization of hTFIIIC will be required to resolve in more detail the structure of this transcription factor and its interaction with 5S rRNA genes.
